切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2019, Vol. 12 ›› Issue (05) : 642 -645. doi: 10.3877/cma.j.issn.1674-6902.2019.05.026

综述

长链非编码RNA(LncRNA)在恶性肿瘤与代谢紊乱相互关系中的作用
王方文1, 陈姝2,()   
  1. 1. 401331 重庆,重庆海吉亚肿瘤医院肿瘤中心
    2. 400042 重庆,陆军军医大学(第三军医大学)大坪医院肿瘤中心
  • 收稿日期:2019-03-17 出版日期:2019-10-20
  • 通信作者: 陈姝

Roles of long non­coding RNA (LncRNA) in the relationship between malignant tumors and metabolic disorders

Fangwen Wang1, Shu Chen2()   

  • Received:2019-03-17 Published:2019-10-20
  • Corresponding author: Shu Chen
引用本文:

王方文, 陈姝. 长链非编码RNA(LncRNA)在恶性肿瘤与代谢紊乱相互关系中的作用[J/OL]. 中华肺部疾病杂志(电子版), 2019, 12(05): 642-645.

Fangwen Wang, Shu Chen. Roles of long non­coding RNA (LncRNA) in the relationship between malignant tumors and metabolic disorders[J/OL]. Chinese Journal of Lung Diseases(Electronic Edition), 2019, 12(05): 642-645.

23
Hamilton S, de Cabo R, Bernier M. Maternally expressed gene 3 in metabolic programming[J]. Biochim Biophys Acta Gene Regul Mech, 2019, doi: 10.1016/j.bbagrm.2019.06.007.
24
Zhang J, Lin Z, Gao Y, et al. Downregulation of long noncoding rna meg3 is associated with poor prognosis and promoter hypermethylation in cervical cancer[J]. J Exp Clin Cancer Res, 2017, 36(1): 5.
25
Zhang Y, Wu J, Jing H, et al. Long noncoding rna meg3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating nf-kappab and p53[J]. J Cell Biochem, 2019, 120(4): 6789-6797.
26
Hao B, Yu M, Sang C, et al. Dyslipidemia and non-small cell lung cancer risk in chinese population: A case-control study[J]. Lipids Health Dis, 2018, 17(1): 278.
27
Kachhawa P, Kachhawa K, Agrawal D, et al. Association of dyslipidemia,increased insulin resistance, and serum ca 15-3 with increased risk of breast cancer in urban areas of north and central india[J]. J Midlife Health, 2018, 9(2): 85-91.
28
Rantaniemi L, Tammela TLJ, Kujala P, et al. Blood cholesterol, tumor clinical characteristics and risk of prostate cancer progression after radical prostatectomy[J]. Scand J Urol, 2018, 52(4): 269-276.
29
Al-Bahlani S, Al-Lawati H, Al-Adawi M, et al. Fatty acid synthase regulates the chemosensitivity of breast cancer cells to cisplatin-induced apoptosis[J]. Apoptosis, 2017, 22(6): 865-876.
30
Wright HJ, Hou J, Xu B, et al. Cdcp1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation[J]. Proc Natl Acad Sci U S A, 2017, 114(32): E6556-E6565.
31
Ali A, Levantini E, Teo JT, et al. Fatty acid synthase mediates egfr palmitoylation in egfr mutated non-small cell lung cancer[J]. EMBO Mol Med, 2018, 10(3): doi: 10.15252/emmm.201708313.
32
Lu C, Ma J, Cai D. Increased haglr expression promotes non-small cell lung cancer proliferation and invasion via enhanced de novo lipogenesis[J]. Tumour Biol, 2017, 39(4): 1010428317697574.
33
Zhou Q, Chen F, Zhao J, et al. Long non-coding rna pvt1 promotes osteosarcoma development by acting as a molecular sponge to regulate mir-195[J]. Oncotarget, 2016, 7(50): 82620-82633.
34
Shang C, Wang W, Liao Y, et al. Lnmicc promotes nodal metastasis of cervical cancer by reprogramming fatty acid metabolism[J]. Cancer Res, 2018, 78(4): 877-890.
35
Mazar J, Zhao W, Khalil AM, et al. The functional characterization of long noncoding rna spry4-it1 in human melanoma cells[J]. Oncotarget, 2014, 5(19): 8959-8969.
36
Wang J, Zhang X, Chen W, et al. Regulatory roles of long noncoding rnas implicated in cancer hallmarks[J]. Int J Cancer, 2019, doi: 10.1002/ijc.32277.
37
Li X, Hou L, Cheng Z, et al. Overexpression of gas5 inhibits abnormal activation of wnt/beta-catenin signaling pathway in myocardial tissues of rats with coronary artery disease[J]. J Cell Physiol, 2019, 234(7): 11348-11359.
38
Yu F, Geng W, Dong P, et al. Lncrna-meg3 inhibits activation of hepatic stellate cells through smo protein and mir-212[J]. Cell Death Dis, 2018, 9(10): 1014.
39
Gonzalez-Nahm S, Mendez M, Robinson W, et al. Low maternal adherence to a mediterranean diet is associated with increase in methylation at the meg3-ig differentially methylated region in female infants[J]. Environ Epigenet, 2017, 3(2): dvx007.
40
Varghese E, Samuel SM, Sadiq Z, et al. Anti-Cancer Agents in Proliferation and Cell Death: The Calcium Connection[J].Int J Mol Sci, 2019, 20(12): doi: 10.3390/ijms20123017.
41
杨 剑,许红霞. 肿瘤矿物质代谢调节治疗[J]. 肿瘤代谢与营养电子杂志,2016, 3(3): 149-154.
42
Curtis EM, Murray R, Titcombe P, et al. Perinatal DNA methylation at cdkn2a is associated with offspring bone mass: Findings from the southampton women′s survey[J]. J Bone Miner Res, 2017, 32(10): 2030-2040.
43
Hadji F, Boulanger MC, Guay SP, et al. Altered DNA methylation of long noncoding rna h19 in calcific aortic valve disease promotes mineralization by silencing notch1[J]. Circulation, 2016, 134(23): 1848-1862.
44
Bikle DD, Jiang Y, Nguyen T, et al. Disruption of vitamin d and calcium signaling in keratinocytes predisposes to skin cancer[J]. Front Physiol, 2016, 7: 296.
45
Xu Y, Luo X, He W, et al. Long non-coding rna pvt1/mir-150/hig2 axis regulates the proliferation, invasion and the balance of iron metabolism of hepatocellular carcinoma[J]. Cell Physiol Biochem, 2018, 49(4): 1403-1419.
46
Sheng L, Ye L, Zhang D, et al. New insights into the long non-coding rna sra: Physiological functions and mechanisms of action[J]. Front Med (Lausanne), 2018,5:244.
1
曹毛毛,陈万青. 中国恶性肿瘤流行情况及防控现状[J]. 中国肿瘤临床,2019, 46(3): 145-149.
2
Watanabe J, Kakehi E, Kotani K, et al. Metabolic syndrome is a risk factor for cancer mortality in the general japanese population: The jichi medical school cohort study[J]. Diabetol Metab Syndr, 2019, 11: 3.
3
Gathirua-Mwangi WG, Monahan PO, Murage MJ, et al. Metabolic syndrome and total cancer mortality in the third national health and nutrition examination survey[J]. Cancer Causes Control, 2017, 28(2): 127-136.
4
Drake I, Gullberg B, Sonestedt E, et al. Type 2 diabetes, adiposity and cancer morbidity and mortality risk taking into account competing risk of noncancer deaths in a prospective cohort setting[J]. Int J Cancer, 2017, 141(6): 1170-1180.
5
Nasserinejad M, Baghestani AR, Shojaee S, et al. Diabetes mellitus and hypertension increase the risk of colorectal cancer mortality; a robust bayesian adjustment analysis[J]. Gastroenterol Hepatol Bed Bench, 2017, 10(Suppl1): S44-S47.
6
Peng F, Hu D, Lin X, et al. An in-depth prognostic analysis of baseline blood lipids in predicting postoperative colorectal cancer mortality: The fiesta study[J]. Cancer Epidemiol, 2018, 52: 148-157.
7
Katzke VA, Sookthai D, Johnson T, et al. Blood lipids and lipoproteins in relation to incidence and mortality risks for cvd and cancer in the prospective epic-heidelberg cohort[J]. BMC Med, 2017, 15(1): 218.
8
Pramanik KC, Makena MR, Bhowmick K, et al. Advancement of nf-kappab signaling pathway: A novel target in pancreatic cancer[J]. Int J Mol Sci, 2018, 19(12). pii: E3890.
9
Ighodaro OM. Molecular pathways associated with oxidative stress in diabetes mellitus[J]. Biomed Pharmacother, 2018, 108: 656-662.
10
Wang J, Li J, Cao N, et al. Resveratrol, an activator of SIRT1, induces protective autophagy in non-small-cell lung cancer via inhibiting Akt/mTOR and activating p38-MAPK[J]. Onco Targets Ther, 2018, 11: 7777-7786.
11
Parida S, Siddharth S, Sharma D. Adiponectin, obesity, and cancer:Clash of the bigwigs in health and disease[J]. Int J Mol Sci, 2019, 20(10). pii: E2519.
12
Ramzan AA, Bitler BG, Hicks D, et al. Adiponectin receptor agonist adiporon induces apoptotic cell death and suppresses proliferation in human ovarian cancer cells[J]. Mol Cell Biochem, 2019, doi: 10.1007/s11010-019-03586-9.
13
Lee PS, Chiou YS, Ho CT, et al. Chemoprevention by resveratrol and pterostilbene: Targeting on epigenetic regulation[J]. BioFactors, 2018, 44(1): 26-35.
14
Chen S, Tao M, Zhao L, et al. The association between diabetes/hyperglycemia and the prognosis of cervical cancer patients: A systematic review and meta-analysis[J]. Medicine (Baltimore), 2017, 96(40): e7981.
15
Scappaticcio L, Maiorino MI, Bellastella G, et al. Insights into the relationships between diabetes, prediabetes, and cancer. Endocrine[J]. Endocrine, 2017, 56(2): 231-239.
16
Klil-Drori AJ, Azoulay L, Pollak MN. Cancer, obesity, diabetes, and antidiabetic drugs: Is the fog clearing?[J]. Nat Rev Clin Oncol, 2017, 14(2): 85-99.
17
Sun H, Huang Z, Sheng W, et al. Emerging roles of long non-coding RNAs in tumor metabolism[J]. J Hematol Oncol, 2018, 11(1): 106-122.
18
Kong Y, Hsieh CH, Alonso LC. Anril: A lncrna at the cdkn2a/b locus with roles in cancer and metabolic disease[J]. Front Endocrinol (Lausanne), 2018, 9: 405.
19
Liu X, Gan B. Lncrna nbr2 modulates cancer cell sensitivity to phenformin through glut1[J]. Cell cycle, 2016, 15(24): 3471-3481.
20
Yang F, Zhang H, Mei Y, et al. Reciprocal regulation of hif-1alpha and lincrna-p21 modulates the warburg effect[J]. Mol Cell, 2014, 53(1): 88-100.
21
Luo M, Li Z, Wang W, et al. Long non-coding rna h19 increases bladder cancer metastasis by associating with ezh2 and inhibiting e-cadherin expression[J]. Cancer Lett, 2013, 333(2): 213-221.
22
Gao Y, Wu F, Zhou J, et al. The h19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells[J]. Nucleic Acids Res, 2014, 42(22): 13799-13811.
[1] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[2] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[3] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[4] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[5] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[6] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[7] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[8] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[9] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[10] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[11] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[12] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[13] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[14] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[15] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?